The UCSC Genome Sequencing Center is now available to accept samples from investigators at other academic institutions as well as regional biotechnology companies. The UCSC Genome Sequencing Center ...
ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17). Characterization of molecular response and progression ...
Next-generation sequencing (NGS) has arrived. “The expansion of users and applications shows no signs of abating,” notes Michael Rhodes, Ph.D., senior manager, SOLiD Sequencing at Applied Biosystems, ...
Our Lab established next-generation sequencing (NGS) in 2017 to detect molecular alterations in solid tumors for diagnosis and to identify therapeutic targets. Our Lab is referral for various regional ...
Prognostic significance of LINE-1 methylation level in the upper gastrointestinal cancer. Prospective study of oncogenic mutations in circulating cell-free DNA (cfDNA) using a multiplex sequencing ...
Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand, targeted next-generation sequencing (NGS) panels are useful in clinical ...
Recent technological innovations in next-generation sequencing (NGS) have users spoiled for choice. At first, new options began trickling in. But then the floodgates opened in 2022 as several new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback